{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:23:38Z","timestamp":1783995818111,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1038\/sj.bmt.1703394","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:14:57Z","timestamp":1031249697000},"page":"373-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation"],"prefix":"10.1038","volume":"29","author":[{"given":"JH","family":"Antin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SJ","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RJ","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JLM","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,3,14]]},"reference":[{"key":"BF1703394_CR1","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.4049\/jimmunol.141.10.3349","volume":"141","author":"MG Cleveland","year":"1988","unstructured":"Cleveland MG, Annabale CR, Klimpel GR . In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease J Immun 1988 141: 3349 3356","journal-title":"J Immun"},{"key":"BF1703394_CR2","first-page":"209","volume":"7","author":"AM Dickinson","year":"1991","unstructured":"Dickinson AM, Sviland L, Dunn J et al. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro skin explant model Bone Marrow Transplant 1991 7: 209 216","journal-title":"Bone Marrow Transplant"},{"key":"BF1703394_CR3","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood.V86.3.890.890","volume":"86","author":"E Holler","year":"1995","unstructured":"Holler E, Kolb HJ, Mitterm\u00fcller J et al. Modulation of acute graft-versus-host disease after allogeneic bone marrow transplantation by tumor necrosis factor \u03b1 (TNF\u03b1) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing TNF\u03b1 (MAK 195F) Blood 1995 86: 890 899","journal-title":"Blood"},{"key":"BF1703394_CR4","doi-asserted-by":"publisher","first-page":"105s","DOI":"10.1111\/1523-1747.ep12874955","volume":"95","author":"RC McKenzie","year":"1990","unstructured":"McKenzie RC, Sauder DN . The role of keratinocyte cytokines in inflammation and immunity J Invest Dermatol 1990 95: 105s 107s","journal-title":"J Invest Dermatol"},{"key":"BF1703394_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1084\/jem.166.5.1280","volume":"166","author":"PF Piguet","year":"1987","unstructured":"Piguet PF, Grau GE, Allet B, Vassali PJ . Tumor necrosis factor\/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease J Exp Med 1987 166: 1280 1289","journal-title":"J Exp Med"},{"key":"BF1703394_CR6","first-page":"99","volume":"15","author":"M Remberger","year":"1995","unstructured":"Remberger M, Ringd\u00e9n O, Markling L . TNF\u03b1 levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD Bone Marrow Transplant 1995 15: 99 104","journal-title":"Bone Marrow Transplant"},{"key":"BF1703394_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/0008-8749(91)90307-W","volume":"134","author":"SR Smith","year":"1991","unstructured":"Smith SR, Terminelli C, Kenworthy-Bott L, Phillips DL . A study of cytokine production in acute graft-vs-host disease Cell Immunol 1991 134: 336 348","journal-title":"Cell Immunol"},{"key":"BF1703394_CR8","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood.V86.6.2429.bloodjournal8662429","volume":"86","author":"M Sykes","year":"1995","unstructured":"Sykes M, Szot GL, Nguyen PL, Pearson DA . Interleukin-12 inhibits murine graft-versus-host disease Blood 1995 86: 2429 2438","journal-title":"Blood"},{"key":"BF1703394_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/00007890-199711150-00018","volume":"64","author":"YG Yang","year":"1997","unstructured":"Yang YG, Dey B, Sergio JJ, Sykes M . Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype-mismatched murine bone marrow transplantation model Transplantation 1997 64: 1343 1352","journal-title":"Transplantation"},{"key":"BF1703394_CR10","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood.V90.11.4651","volume":"90","author":"YG Yang","year":"1997","unstructured":"Yang YG, Sergio JJ, Pearson DA et al. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice Blood 1997 90: 4651 4660","journal-title":"Blood"},{"key":"BF1703394_CR11","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V84.4.1342.1342","volume":"84","author":"JH Antin","year":"1994","unstructured":"Antin JH, Weinstein HJ, Guinan EC et al. Recombinant interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease Blood 1994 84: 1342 1348","journal-title":"Blood"},{"key":"BF1703394_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/00007890-199609150-00015","volume":"62","author":"PL McCarthy Jr","year":"1996","unstructured":"McCarthy PL Jr, Williams L, Harris-Bacile M et al. A clinical phase I\/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease Transplantation 1996 62: 626 631","journal-title":"Transplantation"},{"key":"BF1703394_CR13","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","volume":"86","author":"L Pan","year":"1995","unstructured":"Pan L, Delmonte J Jr, Jalonen CK, Ferrara JLM . Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease Blood 1995 86: 4422 4429","journal-title":"Blood"},{"key":"BF1703394_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S1368-8375(00)00012-9","volume":"36","author":"ST Sonis","year":"2000","unstructured":"Sonis ST, Peterson RL, Edwards LJ et al. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters Oral Oncol 2000 36: 373 381","journal-title":"Oral Oncol"},{"key":"BF1703394_CR15","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","volume":"95","author":"GR Hill","year":"2000","unstructured":"Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 2000 95: 2754 2759","journal-title":"Blood"},{"key":"BF1703394_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1172\/JCI3132","volume":"102","author":"GR Hill","year":"1998","unstructured":"Hill GR, Cooke KR, Teshima T et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation J Clin Invest 1998 102: 115 123","journal-title":"J Clin Invest"},{"key":"BF1703394_CR17","doi-asserted-by":"crossref","first-page":"204a","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"G Hill","year":"1997","unstructured":"Hill G, Cooke K, Crawford J et al. IL-11 reduces the severity of graft-versus-host disease following allogeneic BMT Blood 1997 90: (Suppl. 1) 204a","journal-title":"Blood"},{"key":"BF1703394_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","volume":"97","author":"P Rowlings","year":"1997","unstructured":"Rowlings P, Przepiorka D, Klein J et al. IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade Br J Haematol 1997 97: 855 864","journal-title":"Br J Haematol"},{"key":"BF1703394_CR19","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading Bone Marrow Transplant 1995 15: 825 828","journal-title":"Bone Marrow Transplant"},{"key":"BF1703394_CR20","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis ST, Oster G, Fuchs H et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation J Clin Oncol 2001 19: 2201 2205","journal-title":"J Clin Oncol"},{"key":"BF1703394_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204 217","journal-title":"Am J Med"},{"key":"BF1703394_CR22","first-page":"895","volume":"149","author":"R Peterson","year":"1996","unstructured":"Peterson R, Bozza M, Dorner A . Interleukin-11 induces intestinal epithelial cell growth arrest though effects on retinoblastoma protein phosphorylation Am J Pathol 1996 149: 895 902","journal-title":"Am J Pathol"},{"key":"BF1703394_CR23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood.V83.1.33.33","volume":"83","author":"X Du","year":"1994","unstructured":"Du X, Coerschuk C, Orazi A, Williams D . A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy Blood 1994 83: 33 37","journal-title":"Blood"},{"key":"BF1703394_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ijc.2910620321","volume":"62","author":"CS Potten","year":"1995","unstructured":"Potten CS . Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation Int J Cancer 1995 62: 356 361","journal-title":"Int J Cancer"},{"key":"BF1703394_CR25","first-page":"33","volume":"75","author":"A Orazi","year":"1996","unstructured":"Orazi A, Du X, Yang Z et al. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation Lab Invest 1996 75: 33 42","journal-title":"Lab Invest"},{"key":"BF1703394_CR26","first-page":"545","volume":"272","author":"X Du","year":"1997","unstructured":"Du X, Liu Q, Yang Z et al. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis Am J Physiol 1997 272: 545 552","journal-title":"Am J Physiol"},{"key":"BF1703394_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/stem.140452","volume":"14","author":"CS Potten","year":"1996","unstructured":"Potten CS . Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time Stem Cells 1996 14: 452 459","journal-title":"Stem Cells"},{"key":"BF1703394_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0964-1955(95)00015-A","volume":"32B","author":"S Sonis","year":"1995","unstructured":"Sonis S, Muska A, O'Brien J et al. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11 Eur J Cancer B Oral Oncol 1995 32B: 261 266","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"BF1703394_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1006\/cyto.1997.0208","volume":"9","author":"ST Sonis","year":"1997","unstructured":"Sonis ST, Van Vugt AG, McDonald J et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters Cytokine 1997 9: 605 612","journal-title":"Cytokine"},{"key":"BF1703394_CR30","first-page":"222a","volume":"90","author":"A Rapoport","year":"1997","unstructured":"Rapoport A, Watelet L, Linder T et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic marrow transplants Blood 1997 90: (Suppl. 1) 222a","journal-title":"Blood"},{"key":"BF1703394_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S1083-8791(98)50002-X","volume":"4","author":"JJ Vredenburgh","year":"1998","unstructured":"Vredenburgh JJ, Hussein A, Fisher D et al. A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer Biol Blood Marrow Transplant 1998 4: 134 141","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1703394_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/00912700022009521","volume":"40","author":"KH Dykstra","year":"2000","unstructured":"Dykstra KH, Rogge H, Stone A et al. Mechanism and amelioration of recombinant human interleukin-11 (rhIL-11)-induced anemia in healthy subjects J Clin Pharmacol 2000 40: 880 888","journal-title":"J Clin Pharmacol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T22:21:44Z","timestamp":1682029304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["BF1703394"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703394","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]},"assertion":[{"value":"8 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}